Segment Reporting (Tables)

12 Months Ended

Dec. 31, 2014

Segment information is as follows:



Balance Sheet Data:
	As of December 31, 2014
	Ligand		CyDex		Total
Total Assets	$	184,215	$	73,814	$	258,029

	As of December 31, 2013
	Ligand		CyDex		Total
Total Assets	$	38,408	$	66,305	$	104,713



	For the year ended December 31, 2014
	Ligand			CyDex			Total
Net revenues from external customers	$	27,174		$	37,364		$	64,538
Operating income	(2,372		)	21,998			19,626
Depreciation and amortization expense	253			2,404			2,657
Income tax (expense) benefit from continuing operations	5,106			(5,516		)	(410		)
Interest expense, net	4,860			—			4,860

	For the year ended December 31, 2013
	Ligand			CyDex			Total
Net revenues from external customers	$	21,436		$	27,537		$	48,973
Operating (loss) income	253			14,690			14,943
Depreciation and amortization expense	233			2,430			2,663
Write-off of in-process research and development	—			480			480
Income tax benefit from continuing operations	(419		)	45			(374		)
Interest expense	2,077			—			2,077
Gain on sale of Avinza	2,588			—			2,588

	For the year ended December 31, 2012
	Ligand			CyDex			Total
Net revenues from external customers	$	19,582		$	11,806		$	31,388
Operating (loss) income	(919		)	1,112			$	193
Depreciation and amortization expense	222			2,505			$	2,727
Interest expense, net	2,924			—			$	2,924
Income tax benefit from continuing operations	1,096			95			$	1,191
Gain on sale of Avinza	3,656			—			$	3,656
Income tax expense from discontinuing operations	(1,509		)	—			$	(1,509	)

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References+ Details